Parabolic Drugs Ltd.
| BSE: 533211 | Sector: Health care |
| NSE: PARABDRUGS | ISIN Code: INE618H01016 |
| BSE 00:00 | 25 Jan | Parabolic Drugs Ltd |
| NSE 05:30 | 01 Jan | Parabolic Drugs Ltd |
| OPEN | 5.70 |
| PREVIOUS CLOSE | 5.70 |
| VOLUME | 21 |
| 52-Week high | 6.96 |
| 52-Week low | 2.05 |
| P/E | |
| Mkt Cap.(Rs cr) | 35 |
| Buy Price | 6.35 |
| Buy Qty | 1649.00 |
| Sell Price | 5.70 |
| Sell Qty | 56019.00 |
Parabolic Drugs Ltd. (PARABDRUGS) - Announcements
-
Parabolic Drugs Ltd Outcome Of Board Meeting Held On 11.02.2021 And Intimation Of Financial Results For The Quarter And
11/02/2021 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Corporate Insolvency Resolution Process (CIRP)-Public Announcement
08/02/2021 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Board Meeting Intimation for Un-Audited Quarterly Financial Results For The Quarter And Nine Months
05/02/2021 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Fixation Of Record Date For Suspension Of Trading Of Units/Scrip
25/01/2021 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
22/01/2021 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Corporate Action-Intimation of Delisting
22/01/2021 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Shareholding for the Period Ended December 31 2020
21/01/2021 | bse
-
Parabolic Drugs Ltd Statement Of Investor Complaints For The Quarter Ended December 2020
21/01/2021 | bse
-
Parabolic Drugs Ltd Corporate Action-Intimation of Delisting
19/01/2021 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
16/01/2021 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Closure of Trading Window
30/12/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Dis
14/12/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Outcome Of Board Meeting
07/12/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Board Meeting Intimation for Considering Revised Unaudited Quarterly Financial Results For The Quart
30/11/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd OUTCOME OF BOARD MEETING
13/11/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Board Meeting Intimation for Revised Intimation Under Regulation 29 Of SEB (LODR) Regulations 2015 R
12/11/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Board Meeting Intimation for Intimation Under Regulation 29 Of SEB (LODR) Regulations 2015 Regarding
06/11/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Reg
28/10/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations & Disclosure Requirements)
27/10/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Intimation Of Notice Of Board Meeting- Clarification For Financial Results For Quarter Ending 30 Jun
22/10/2020 | bse |
Downlaod PDF
Quick Links for Parabolic Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
